Challenge: Current cancer treatments are a shotgun effect - killing the cancer cells but also healthy cells. How do you direct the cancer drugs only to the cancer cells?
Innovation Delivered: Oceanit's biomedical and nanotechnology teams are working together to develop a drug delivery platform which utilizes carbon nanotubes (CNTs) as a drug delivery vehicle. CNTs are loaded with a cancer drug molecule payload, and functionalized with an antibody to seek out cancer cells, such as breast and prostate cancer. Animal tests have shown breakthrough results leading to follow-on funding by the Department of Defense.